Often, secondary AML is overrepresented with biallelic or multi-hit TP53 disease, which contributes to significant genomic instability that manifests as complex karyotypes, chromothripsis, or large structural abnormalities [55,56]. The gene discussed is TP53; the disease is acute myeloid leukemia.